Carvedilol and Alverine in Portal Hypertension
NCT06696248
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
NOT_YET_RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Hypertension, Portal
Interventions
DRUG:
Carvedilol and alverine
Sponsor
Shanghai Changzheng Hospital
Collaborators
[object Object]
[object Object]